Light adjustable lenses offer stability of refraction

Article

Residual myopic errors can be successfully corrected postoperatively by using light-adjustable lens technology (LAL) in cataract patients, concludes a study published online by Ophthalmology.

Residual myopic errors can be successfully corrected postoperatively by using light-adjustable lens technology (LAL) in cataract patients, concludes a study published online by Ophthalmology.

Arturo Chayet from the Codet Vision Institute, Mexico and colleagues from the US conducted a prospective study implanting LALs that would purposely result in myopic errors of up to -1.5 D in 14 eyes of 14 patients. The LALs were treated with a spatial intensity profile to induce a targeted myopic refractive change. The LALs were treated again once the desired correction was achieved in order to 'lock in' the lens power.

Thirteen of the 14 eyes attained 0.25 D of the target refraction one day following the 'lock-in' and 100% of eyes achieved target refraction adjustment within 0.5 D during the 9-month follow-up period. No changes were recorded in manifest spherical refraction between the first day post 'lock-in' and the end of follow-up.

The researchers noted that the mean rate of refractive change was 0.006 D per month, making this treatment approach approximately six times more stable than laser corneal refractive procedures.

Click here to read the full abstract.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.